•  
  •  
  •  
  •  

2025-08-31 23:55:51

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  Approval

IPO News

  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
  • Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO
  • Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO
  • IT Solutions provider Orient Technologies gets Sebi nod for IPO
  • Gala Precision Engineering gets Sebi nod for IPO
  • Noida-based Interarch Building Products Limited gets SEBI nod for IPO
  • Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO
  • Allied Blenders and Distillers Limited gets Sebi nod for Rs 1500 crore IPO
  • Sanstar Limited, gets SEBI nod to float IPO
  • Asirvad Micro Finance Limited gets Sebi nod for IPO
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Fairfax-backed Go Digit General Insurance gets Sebi nod for IPO
  • Gopal Snacks Limited gets Sebi nod for Rs 650 crore IPO
  • Juniper Hotels gets Sebi nod for its Rs 1,800 crore IPO
  • Stanley Lifestyles gets Sebi nod for IPO
  • Onest and Shiva Pharmachem gets Sebi nod for IPO
  • Mukka Proteins Limited gets Sebi Nod for IPO
  • Ludhiana-based Auto Component Maker Happy Forgings Limited receives Sebi nod to float its IPO
  • Cello World Limited gets Sebi nod for its Rs 1750 crore IPO
  • ESAF Small Finance Bank gets Sebi nod for IPO
  • MUFTI Owner Credo Brands Marketing gets Sebi nod for IPO
  • SAMHI Hotels and Motisons Jewellers gets Sebi nod for IPO
  • Jupiter Life Line Hospitals gets SEBI Nod for IPO

Stock Report

  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Lehar Footwears Ltd receives BIS approval for PU Footwear products
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Madhvani Group Begins Formal Acquisition of HNGIL After NCLT Approval
  • CCS approves procurement of 97 LCA Mk-1A from HAL
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg
  • Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags
  • Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
  • Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
  • Shilpa Medicare announces the approval of Nor Ursodeoxycholic Acid Tablets 500 mg for the treatment of Non‐Alcoholic Fatty Liver Disease in India
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • CreditAccess Grameen appoints Mr. Ganesh Narayanan as MD & CEO, Mr. Udaya Kumar Hebbar joins the Board as Non-Executive Director
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg, and 400 mg
  • Dixon Technologies India Ltd receives approval from MEITY for JV
  • Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
  • GHCL Ltd receives lease renewal approval for Khadsaliya Lignite Mines
  • Aurum PropTech receives SEBI approval for SM REIT
  • Savani Financials Ltd receives RBI NOC for name change to Mantra Capital Ltd
  • Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™
  • Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg
  • Biocon Biologics receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars
  • Lupin receives approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets

Industry News

  • RBI grants NBFC license to Equirus Group
  • NCLT approves slice and North East Small Finance Bank's Merger
  • NSE launches WTI Crude Oil and Natural Gas futures contracts
  • Zero To One, an angel network, gets SEBI nod to launch INR 300cr Alternative Investment Fund
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024